Original Article
IJMDC. 2020; 4(9): 1375-1389
Adjuvant TaibUVID nutritional supplements proved promising for novel safe COVID-19 public prophylaxis and treatment: enhancing immunity and decreasing morbidity period for better outcomes (A retrospective study)
Authors: Salah Mohamed El Sayed, Saleh A. Bahashwan, Moutasem Salih Aboonq, Hussam Baghdadi, Mo'men Elshzley, Ahmed M. Okashah, Amr Gamal El Rashedy, Rabab AbouElMagd Ahmed, Yasmeen Talal Aljehani, Rehab El-Tahlawi, Manal Mohamed Helmy Nabo, Osama Hamouda, Abdul-Rahman El-Murr, Tamer Mohamed Abdul-Latif, Hany Salah Mahmoud, Mostafa Abu-Elnaga, Mahmoud Mohamed Hassan.
ABSTRACT
Background: We recently suggested TaibUVID nutritional supplements (containing natural honey, Nigella sativa, chamomile, costus, fennel, and/or senna) of prophetic medicine as adjuvants to pharmacological treatments to potentiate immunity and combat the SARS-COV-2 virus and COVID-19 pandemic. The present study aims at assessing the safety and effectiveness of taking adjuvant TaibUVID nutritional supplements. Methodology: A prospective controlled trial was not applicable. However, a retrospective data analysis of ten confirmed COVID-19 patients (many of them have radiological findings) in Egypt was carried out. Patients knew about the TaibUVID nutritional supplements via social media. An online questionnaire was also distributed via social media to investigate patients opinions regarding the safety and effectiveness of taking adjuvant TaibUVID nutritional supplements. Paired sample t-test and Statistical Package for the Social Sciences version 16 were used for data analysis. Results: TaibUVID induced lymphocytosis and increased the percentage of lymphocytes from 21% to 53.4% within few days, i.e., may increase B lymphocytes (humoral immunity) and T lymphocytes (cell-mediated immunity). COVID-19 patients (n = 3) taking pharmacological treatments only needed a significantly longer duration (p < 0.05) till the beginning of improvement or death (9.66 ± 1.33 days) versus 3.5± 0.22 days for COVID-19 patients who received pharmacological treatments with TaibUVID nutritional supplements (n = 10, majority were physicians). COVID-19 patients (n = 3, all were physicians) taking pharmacological treatments only needed a significantly longer duration (p < 0.05) till complete recovery or death (12.33 ± 2.73 days) versus 7.3 ± 1.01 days for those receiving pharmacological treatments with TaibUVID nutritional supplements (n = 10, majority were physicians). In the questionnaire, 33 out of 40 patients (82.5%) reported no side effects after TaibUVID administration. 7 patients (17.5%) reported few side effects (hyperglycemia and diarrhea) after TaibUVID intake. Diarrhea may be due to senna (recommended but optional). Hyperglycemia may occur with non-natural honey. 38 patients (90%) reported improvement by 25%-100% after intake of TaibUVID nutritional supplements. 20 patients (50%) confirmed getting health benefits after TaibUVID inhalation therapy. 22 patients (55%) reported they know other COVID-19 patients not taking TaibUVID supplements and had delayed improvements. Conclusion: TaibUVID enhanced immunity and potentiated a safe rapid recovery of COVID-19 infection. It is strongly advisable to add TaibUVID nutritional supplements to pharmacological protocols to fasten patients' recovery. TaibUVID supplements are advisable for public and contacts prophylaxis. "TaibUVID for all" health campaigns are recommended. More clinical research studies are recommended. Limitation: This study is limited by the few number of patients and lack of detailed investigations.
Keywords:
COVID-19, TaibUVID, TaibUVID Forte, TaibUVID inhalation therapy, Nigella sativa, natural honey, chamomile, senna, fennel, costus
Authors
Salah Mohamed El Sayed
Prophetic Medicine and Integrative Medicine Course and Research, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia
PubMed articlesGoogle scholar articles
Saleh A Bahashwan
Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia
PubMed articlesGoogle scholar articles
Moutasem Salih Aboonq
Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt
PubMed articlesGoogle scholar articles
Hussam Baghdadi
Department of Pharmacology, Taibah Faculty of Pharmacy, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia
PubMed articlesGoogle scholar articles
Mo'men Elshzley
Department of Medical Physiology, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia
PubMed articlesGoogle scholar articles
Ahmed M Okashah
Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia
PubMed articlesGoogle scholar articles
Amr Gamal El Rashedy
Department of Medicine, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia
PubMed articlesGoogle scholar articles
Rabab AbouElMagd Ahmed
Department of Occupational Diseases and Toxigenomics, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt
PubMed articlesGoogle scholar articles
Yasmeen Talal Aljehani
Academic Affairs Director And Consultant Clinical Immunologist, Al-Madinah Directorate of Health, Al- Madinah Al-Munawwarah, Ministry of Health, Saudi Arabia
PubMed articlesGoogle scholar articles
Rehab El-Tahlawi
Department of Gastroenterology and infectious diseases, Sohag Fever Hospital, Sohag, Egypt
PubMed articlesGoogle scholar articles
Manal Mohamed Helmy Nabo
Department of Psychiatry, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada
PubMed articlesGoogle scholar articles
Osama Hamouda
Institute of Genetic Engineering, City for Scientific Research and Technological Applications, Alexandria, Egypt
PubMed articlesGoogle scholar articles
Abdul-Rahman El-Murr
Director of The Research and Studies Department of Health affairs in Al-Madinah Region, Consultant family Medicine and trainer in Family Medicine Program for Postgraduate Studies, Al-Madinah Al-Munawwarah, Saudi Arabia
PubMed articlesGoogle scholar articles
Tamer Mohamed Abdul-Latif
Department of Microbiology, College of Medicine, Taibah University, Saudi Arabia
PubMed articlesGoogle scholar articles
Hany Salah Mahmoud
Department of Microbiology, Faculty of Medicine, Zagazig University, Egypt
PubMed articlesGoogle scholar articles
Mostafa Abu-Elnaga
Division of Pediatric Cardiology, Pediatrics Department, Maternity and Children Hospital, Hail, Saudi Arabia
PubMed articlesGoogle scholar articles
Mahmoud Mohamed Hassan
Prophetic Medicine and Integrative Medicine Course and Research, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia
PubMed articlesGoogle scholar articles
Correspondence to:
. Salah Mohamed El Sayed, Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia.; salahfazara@yahoo.com
Publication history
Received 06 Jul 2020
Accepted 19 Jul 2020
Published online 05 Aug 2020
Published in print 08 Sep 2020
How to cite this article?
Export to EndNote Export to refManPubmed Style
Sayed SME, Bahashwan SA, Aboonq MS, Baghdadi H, Elshzley M, Okashah AM, Rashedy AGE, Ahmed RA, Aljehani YT, El-Tahlawi R, Nabo MMH, Hamouda O, El-Murr A, Abdul-Latif TM, Mahmoud HS, Abu-Elnaga M, Hassan MM. Adjuvant TaibUVID nutritional supplements proved promising for novel safe COVID-19 public prophylaxis and treatment: enhancing immunity and decreasing morbidity period for better outcomes (A retrospective study). IJMDC. 2020; 4(9): 1375-1389. doi:10.24911/IJMDC.51-1594011487
Web Style
Sayed SME, Bahashwan SA, Aboonq MS, Baghdadi H, Elshzley M, Okashah AM, Rashedy AGE, Ahmed RA, Aljehani YT, El-Tahlawi R, Nabo MMH, Hamouda O, El-Murr A, Abdul-Latif TM, Mahmoud HS, Abu-Elnaga M, Hassan MM. Adjuvant TaibUVID nutritional supplements proved promising for novel safe COVID-19 public prophylaxis and treatment: enhancing immunity and decreasing morbidity period for better outcomes (A retrospective study). https://www.ijmdc.com/?mno=26797 [Access: September 30, 2022]. doi:10.24911/IJMDC.51-1594011487
AMA (American Medical Association) Style
Sayed SME, Bahashwan SA, Aboonq MS, Baghdadi H, Elshzley M, Okashah AM, Rashedy AGE, Ahmed RA, Aljehani YT, El-Tahlawi R, Nabo MMH, Hamouda O, El-Murr A, Abdul-Latif TM, Mahmoud HS, Abu-Elnaga M, Hassan MM. Adjuvant TaibUVID nutritional supplements proved promising for novel safe COVID-19 public prophylaxis and treatment: enhancing immunity and decreasing morbidity period for better outcomes (A retrospective study). IJMDC. 2020; 4(9): 1375-1389. doi:10.24911/IJMDC.51-1594011487
Vancouver/ICMJE Style
Sayed SME, Bahashwan SA, Aboonq MS, Baghdadi H, Elshzley M, Okashah AM, Rashedy AGE, Ahmed RA, Aljehani YT, El-Tahlawi R, Nabo MMH, Hamouda O, El-Murr A, Abdul-Latif TM, Mahmoud HS, Abu-Elnaga M, Hassan MM. Adjuvant TaibUVID nutritional supplements proved promising for novel safe COVID-19 public prophylaxis and treatment: enhancing immunity and decreasing morbidity period for better outcomes (A retrospective study). IJMDC. (2020), [cited September 30, 2022]; 4(9): 1375-1389. doi:10.24911/IJMDC.51-1594011487
Harvard Style
Sayed, S. M. E., Bahashwan, . S. A., Aboonq, . M. S., Baghdadi, . H., Elshzley, . M., Okashah, . A. M., Rashedy, . A. G. E., Ahmed, . R. A., Aljehani, . Y. T., El-Tahlawi, . R., Nabo, . M. M. H., Hamouda, . O., El-Murr, . A., Abdul-Latif, . T. M., Mahmoud, . H. S., Abu-Elnaga, . M. & Hassan, . M. M. (2020) Adjuvant TaibUVID nutritional supplements proved promising for novel safe COVID-19 public prophylaxis and treatment: enhancing immunity and decreasing morbidity period for better outcomes (A retrospective study). IJMDC, 4 (9), 1375-1389. doi:10.24911/IJMDC.51-1594011487
Turabian Style
Sayed, Salah Mohamed El, Saleh A. Bahashwan, Moutasem Salih Aboonq, Hussam Baghdadi, Momen Elshzley, Ahmed M. Okashah, Amr Gamal El Rashedy, Rabab AbouElMagd Ahmed, Yasmeen Talal Aljehani, Rehab El-Tahlawi, Manal Mohamed Helmy Nabo, Osama Hamouda, Abdul-Rahman El-Murr, Tamer Mohamed Abdul-Latif, Hany Salah Mahmoud, Mostafa Abu-Elnaga, and Mahmoud Mohamed Hassan. 2020. Adjuvant TaibUVID nutritional supplements proved promising for novel safe COVID-19 public prophylaxis and treatment: enhancing immunity and decreasing morbidity period for better outcomes (A retrospective study). International Journal of Medicine in Developing Countries, 4 (9), 1375-1389. doi:10.24911/IJMDC.51-1594011487
Chicago Style
Sayed, Salah Mohamed El, Saleh A. Bahashwan, Moutasem Salih Aboonq, Hussam Baghdadi, Momen Elshzley, Ahmed M. Okashah, Amr Gamal El Rashedy, Rabab AbouElMagd Ahmed, Yasmeen Talal Aljehani, Rehab El-Tahlawi, Manal Mohamed Helmy Nabo, Osama Hamouda, Abdul-Rahman El-Murr, Tamer Mohamed Abdul-Latif, Hany Salah Mahmoud, Mostafa Abu-Elnaga, and Mahmoud Mohamed Hassan. "Adjuvant TaibUVID nutritional supplements proved promising for novel safe COVID-19 public prophylaxis and treatment: enhancing immunity and decreasing morbidity period for better outcomes (A retrospective study)." International Journal of Medicine in Developing Countries 4 (2020), 1375-1389. doi:10.24911/IJMDC.51-1594011487
MLA (The Modern Language Association) Style
Sayed, Salah Mohamed El, Saleh A. Bahashwan, Moutasem Salih Aboonq, Hussam Baghdadi, Momen Elshzley, Ahmed M. Okashah, Amr Gamal El Rashedy, Rabab AbouElMagd Ahmed, Yasmeen Talal Aljehani, Rehab El-Tahlawi, Manal Mohamed Helmy Nabo, Osama Hamouda, Abdul-Rahman El-Murr, Tamer Mohamed Abdul-Latif, Hany Salah Mahmoud, Mostafa Abu-Elnaga, and Mahmoud Mohamed Hassan. "Adjuvant TaibUVID nutritional supplements proved promising for novel safe COVID-19 public prophylaxis and treatment: enhancing immunity and decreasing morbidity period for better outcomes (A retrospective study)." International Journal of Medicine in Developing Countries 4.9 (2020), 1375-1389. Print. doi:10.24911/IJMDC.51-1594011487
APA (American Psychological Association) Style
Sayed, S. M. E., Bahashwan, . S. A., Aboonq, . M. S., Baghdadi, . H., Elshzley, . M., Okashah, . A. M., Rashedy, . A. G. E., Ahmed, . R. A., Aljehani, . Y. T., El-Tahlawi, . R., Nabo, . M. M. H., Hamouda, . O., El-Murr, . A., Abdul-Latif, . T. M., Mahmoud, . H. S., Abu-Elnaga, . M. & Hassan, . M. M. (2020) Adjuvant TaibUVID nutritional supplements proved promising for novel safe COVID-19 public prophylaxis and treatment: enhancing immunity and decreasing morbidity period for better outcomes (A retrospective study). International Journal of Medicine in Developing Countries, 4 (9), 1375-1389. doi:10.24911/IJMDC.51-1594011487
Article Statistics
Request permissions
If you wish to reuse any part or all of this article please contact the copyright holder, contact@ijmdc.com.
Copyright ©2022 Discover STM Publishing. All Rights Reserved.